Literature DB >> 25655789

Craniosynostosis and risk factors related to thyroid dysfunction.

S L Carmichael1, C Ma, S A Rasmussen, M L Cunningham, M L Browne, C Dosiou, E J Lammer, G M Shaw.   

Abstract

Thyroid disease is a common problem among women of reproductive age but often goes undiagnosed. Maternal thyroid disease has been associated with increased risk of craniosynostosis. We hypothesized that known risk factors for thyroid disease would be associated with risk of craniosynostosis among women not diagnosed with thyroid disease. Analyses included mothers of 1,067 cases and 8,494 population-based controls who were interviewed for the National Birth Defects Prevention Study. We used multivariable logistic regression to estimate adjusted odds ratios (AOR) and 95% confidence intervals (CI). After excluding women with diagnosed thyroid disease, younger maternal age (AOR 0.7, 95% CI 0.6-0.9, for <25 years versus 25-29), black or other race-ethnicity (AOR 0.3, 95% CI 0.2-0.4 and AOR 0.6, 95% CI 0.4-0.8, respectively, relative to non-Hispanic whites), fertility medications or procedures (AOR 1.5, 95% CI 1.2-2.0), and alcohol consumption (AOR 0.8, 95% CI 0.7-0.9) were associated with risk of craniosynostosis, based on confidence intervals that excluded 1.0. These associations with craniosynostosis are consistent with the direction of their association with thyroid dysfunction (i.e., younger age, black race-ethnicity and alcohol consumption are associated with reduced risk and fertility problems are associated with increased risk of thyroid disease). This study thus provides support for the hypothesis that risk factors associated with thyroid dysfunction are also associated with risk of craniosynostosis. Improved understanding of the potential association between maternal thyroid function and craniosynostosis among offspring is important given that craniosynostosis carries significant morbidity and that thyroid disease is under-diagnosed and potentially modifiable.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  birth defects; craniosynostosis; thyroid

Mesh:

Year:  2015        PMID: 25655789      PMCID: PMC4768483          DOI: 10.1002/ajmg.a.36953

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  47 in total

1.  Further evidence for an association between maternal smoking and craniosynostosis.

Authors:  M A Honein; S A Rasmussen
Journal:  Teratology       Date:  2000-09

2.  Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis.

Authors:  Sandra Richardson; Marilyn L Browne; Sonja A Rasmussen; Charlotte M Druschel; Lixian Sun; Ethylin Wang Jabs; Paul A Romitti
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-31

3.  Maternal body mass index as a risk factor for craniosynostosis.

Authors:  Sheree L Boulet; Sonja A Rasmussen; Margaret A Honein
Journal:  Am J Med Genet A       Date:  2010-11       Impact factor: 2.802

4.  Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years.

Authors:  D Daneman; N J Howard
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

5.  A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy.

Authors:  D A Wing; L K Millar; P P Koonings; M N Montoro; J H Mestman
Journal:  Am J Obstet Gynecol       Date:  1994-01       Impact factor: 8.661

6.  Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ruth M Belin; Brad C Astor; Neil R Powe; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

7.  Premature craniosynostosis-a complication of thyroid replacement therapy.

Authors:  J L Penfold; D A Simpson
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

8.  Iron deficiency predicts poor maternal thyroid status during pregnancy.

Authors:  Michael B Zimmermann; Hans Burgi; Richard F Hurrell
Journal:  J Clin Endocrinol Metab       Date:  2007-06-12       Impact factor: 5.958

9.  The association between neonatal thyroxine and craniosynostosis, Texas, 2004-2007.

Authors:  Syed Shahrukh Hashmi; Mark A Canfield; Lisa Marengo; Karen B Moffitt; John W Belmont; Debra Freedenberg; Susan M Tanksley; Philip J Lupo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-10-26

10.  Craniosynostosis and maternal smoking.

Authors:  Suzan L Carmichael; Chen Ma; Sonja A Rasmussen; Margaret A Honein; Edward J Lammer; Gary M Shaw
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-02
View more
  9 in total

1.  Effects of thyroxine exposure on the Twist 1 +/- phenotype: A test of gene-environment interaction modeling for craniosynostosis.

Authors:  Emily L Durham; R Nicole Howie; Laurel Black; Grace Bennfors; Trish E Parsons; Mohammed Elsalanty; Jack C Yu; Seth M Weinberg; James J Cray
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-07-20

Review 2.  Gene/environment interactions in craniosynostosis: A brief review.

Authors:  E L Durham; R N Howie; J J Cray
Journal:  Orthod Craniofac Res       Date:  2017-06       Impact factor: 1.826

3.  Activation of the IGF1 pathway mediates changes in cellular contractility and motility in single-suture craniosynostosis.

Authors:  Zeinab Al-Rekabi; Marsha M Wheeler; Andrea Leonard; Adriane M Fura; Ilsa Juhlin; Christopher Frazar; Joshua D Smith; Sarah S Park; Jennifer A Gustafson; Christine M Clarke; Michael L Cunningham; Nathan J Sniadecki
Journal:  J Cell Sci       Date:  2015-12-11       Impact factor: 5.285

4.  A variant in IL6ST with a selective IL-11 signaling defect in human and mouse.

Authors:  Tobias Schwerd; Freia Krause; Stephen R F Twigg; Andrew O M Wilkie; Dirk Schmidt-Arras; Holm H Uhlig; Dominik Aschenbrenner; Yin-Huai Chen; Uwe Borgmeyer; Miryam Müller; Santiago Manrique; Neele Schumacher; Steven A Wall; Jonathan Jung; Timo Damm; Claus-Christian Glüer; Jürgen Scheller; Stefan Rose-John; E Yvonne Jones; Arian Laurence
Journal:  Bone Res       Date:  2020-06-11       Impact factor: 13.567

5.  Sagittal Synostosis and Its Association With Cognitive, Behavioral, and Psychological Functioning: A Meta-analysis.

Authors:  Amanda J Osborn; Rachel M Roberts; Diana S Dorstyn; Ben G Grave; David J David
Journal:  JAMA Netw Open       Date:  2021-09-01

6.  High risk factors for craniosynostosis during pregnancy: A case-control study.

Authors:  Sotirios Plakas; Evangelos Anagnostou; Angelos Christos Plakas; Maria Piagkou
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2022-03-19

7.  Effects of In Utero Thyroxine Exposure on Murine Cranial Suture Growth.

Authors:  R Nicole Howie; Emily L Durham; Laurel Black; Grace Bennfors; Trish E Parsons; Mohammed E Elsalanty; Jack C Yu; Seth M Weinberg; James J Cray
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

Review 8.  Mouth development.

Authors:  Justin Chen; Laura A Jacox; Francesca Saldanha; Hazel Sive
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-05-17       Impact factor: 5.814

9.  A variant in IL6ST with a selective IL-11 signaling defect in human and mouse.

Authors:  Tobias Schwerd; Freia Krause; Stephen R F Twigg; Andrew O M Wilkie; Dirk Schmidt-Arras; Holm H Uhlig; Dominik Aschenbrenner; Yin-Huai Chen; Uwe Borgmeyer; Miryam Müller; Santiago Manrique; Neele Schumacher; Steven A Wall; Jonathan Jung; Timo Damm; Claus-Christian Glüer; Jürgen Scheller; Stefan Rose-John; E Yvonne Jones; Arian Laurence
Journal:  Bone Res       Date:  2020-06-11       Impact factor: 13.567

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.